Human Metabolome Technologies, Inc. (TYO:6090)
Japan · Delayed Price · Currency is JPY 600.00
-23.00 (-3.69%)
Jun 4, 2026, 3:30 PM JST
TYO:6090 Market Cap
TYO:6090 has a market cap or net worth of 3.38 billion as of June 4, 2026. Its market cap has decreased by -13.46% in one year.
Market Cap
3.38B
Enterprise Value
2.02B
Revenue
1.30B
Ranking
n/a
PE Ratio
29.11
Stock Price
600.00
Market Cap Chart
Since December 24, 2013, TYO:6090's market cap has decreased from 11.04B to 3.38B, a decrease of -69.42%. That is a compound annual growth rate of -9.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 3.38B | -9.62% |
| Dec 30, 2025 | 3.74B | 2.79% |
| Dec 30, 2024 | 3.63B | -4.00% |
| Dec 29, 2023 | 3.79B | -5.61% |
| Dec 30, 2022 | 4.01B | 5.39% |
| Dec 30, 2021 | 3.81B | -13.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.22T |
| HOYA Corporation | 8.85T |
| Takeda Pharmaceutical Company | 7.66T |
| Otsuka Holdings | 5.67T |
| Transgenic Group | 3.66B |
| Ribomic | 3.64B |
| Modalis Therapeutics | 3.40B |
| MRT Inc. | 3.39B |